Chromadex Corp Stock Performance
| CDXC Stock | USD 7.44 0.19 2.49% |
Chromadex Corp holds a performance score of 12 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.12, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chromadex Corp will likely underperform. Use Chromadex Corp treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to analyze future returns on Chromadex Corp.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Chromadex Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Chromadex Corp exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 20.4 M |
Chromadex |
Chromadex Corp Relative Risk vs. Return Landscape
If you would invest 350.00 in Chromadex Corp on August 25, 2024 and sell it today you would earn a total of 394.00 from holding Chromadex Corp or generate 112.57% return on investment over 90 days. Chromadex Corp is currently generating 1.4924% in daily expected returns and assumes 9.1713% risk (volatility on return distribution) over the 90 days horizon. In different words, 81% of stocks are less volatile than Chromadex, and 71% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Chromadex Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chromadex Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chromadex Corp, and traders can use it to determine the average amount a Chromadex Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1627
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CDXC | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.17 actual daily | 81 81% of assets are less volatile |
Expected Return
| 1.49 actual daily | 29 71% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Chromadex Corp is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chromadex Corp by adding it to a well-diversified portfolio.
Chromadex Corp Fundamentals Growth
Chromadex Stock prices reflect investors' perceptions of the future prospects and financial health of Chromadex Corp, and Chromadex Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chromadex Stock performance.
| Return On Equity | 0.0482 | ||||
| Return On Asset | 0.0051 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 543.52 M | ||||
| Shares Outstanding | 76.38 M | ||||
| Price To Earning | (19.51) X | ||||
| Price To Book | 16.67 X | ||||
| Price To Sales | 6.36 X | ||||
| Revenue | 83.57 M | ||||
| EBITDA | (3.89 M) | ||||
| Cash And Equivalents | 16.87 M | ||||
| Cash Per Share | 0.25 X | ||||
| Total Debt | 3.28 M | ||||
| Debt To Equity | 0.22 % | ||||
| Book Value Per Share | 0.45 X | ||||
| Cash Flow From Operations | 7.12 M | ||||
| Earnings Per Share | 0.02 X | ||||
| Total Asset | 54.96 M | ||||
| Retained Earnings | (190.46 M) | ||||
| Current Asset | 16.55 M | ||||
| Current Liabilities | 9.59 M | ||||
About Chromadex Corp Performance
By analyzing Chromadex Corp's fundamental ratios, stakeholders can gain valuable insights into Chromadex Corp's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chromadex Corp has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chromadex Corp has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. ChromaDex Corporation is headquartered in Los Angeles, California. Chromadex Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 115 people.Things to note about Chromadex Corp performance evaluation
Checking the ongoing alerts about Chromadex Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chromadex Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chromadex Corp is way too risky over 90 days horizon | |
| Chromadex Corp appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 83.57 M. Net Loss for the year was (4.94 M) with profit before overhead, payroll, taxes, and interest of 42.8 M. | |
| Chromadex Corp has a poor financial position based on the latest SEC disclosures | |
| About 35.0% of the company shares are held by company insiders |
- Analyzing Chromadex Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chromadex Corp's stock is overvalued or undervalued compared to its peers.
- Examining Chromadex Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chromadex Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chromadex Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chromadex Corp's stock. These opinions can provide insight into Chromadex Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chromadex Stock analysis
When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |